Frontage (HKG:1521) recorded a net profit of $0.2 million for the nine months ended Sept. 30, lower than the $9.8 million net profit logged for the corresponding period last year, a Tuesday filing with the Hong Kong Exchange said.
The laboratory and related services provider's revenue for the nine months was $191.1 million, 3.6% lower than HK$XX billion booked a year ago.
The detailed financial results of the company are disclosed in the unaudited third-quarter results for 2024 of the company's controlling shareholder, Hangzhou Tigermed Consulting (HKG: 3347, SHE:300347).
The company's shares were down over 1% on Tuesday's close.
Price (HKD): $0.73, Change: $-0.010, Percent Change: -1.35%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.